Arbutus Biopharma ABUS
NASDAQ ABUS
$4.45 -0.11 (-2.41%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arbutus Biopharma (ABUS) Return on Invested Capital [ROIC] (2017 - 2018)

Updated

Arbutus Biopharma (ABUS) recorded Return on Invested Capital [ROIC] of -23.17% in Q4 2018, up 0.78 percentage points from -23.95% a year earlier and up 19.36 percentage points from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Return on Invested Capital [ROIC] (2017 - 2018) Analysis & Trends

For FY2018, Arbutus Biopharma reported Return on Invested Capital [ROIC] of -42.32%, down 0.25 percentage points from FY2017.

  • Across earlier years, Return on Invested Capital [ROIC] came in at -42.06% in FY2017 (+59.19 pp) and -101.25% in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Arbutus Biopharma 879.47 Mn 506.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -23.17%
Sep 30, 2018 -42.53%
Dec 31, 2017 -23.95%
Sep 30, 2017 -145.86%
Jun 30, 2017 -107.67%
API Access

Arbutus Biopharma Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ABUS&period=max&api_key=YOUR_API_KEY